Chapter 1

After the Boom

Pernod Ricard is the world's second-largest spirits group — a €10.96bn portfolio of premium brands (Absolut, Jameson, Martell, Chivas Regal, Ballantine's) assembled by acquisition and run on premiumisation and pricing. A post-pandemic boom carried sales to a FY2023 record; organic sales have since fallen for two straight years as the United States and China reset at once. The shares trade near €64, roughly two-thirds below their 2021 peak. This chapter orients a reader to the business and sets the question the report exists to answer.

The company: a premium portfolio built by acquisition

Pernod Ricard was created in 1975 from the merger of two French pastis houses — Pernod (founded 1805) and Ricard (1932) — and has spent five decades buying its way to global scale [1]. The defining deals built the shelf a reader would recognise today: Irish Distillers (Jameson) in 1988, Allied Domecq (Ballantine's, Beefeater, Mumm, Perrier-Jouët) in 2005, the Seagram brands (Martell cognac, Chivas Regal, Royal Salute, The Glenlivet) in 2001, and Vin and Sprit (Absolut vodka) in 2008 [2]. The company describes itself as "the world's leading international premium spirits company" [3]; by revenue it sits second behind Diageo. In FY2025 (year ended 30 June 2025) it turned over €10.96bn with about 18,224 employees [4].

The model is straightforward to state and hard to run: own aspirational brands with legal or geographic scarcity (cognac from Cognac, champagne from Champagne, aged Scotch), sell them through mostly in-house distribution across roughly 160 markets, and lift price and mix faster than volume over time. That premiumisation is what has historically turned a low-single-digit volume business into mid-single-digit revenue growth and steady margin expansion.

How it makes money

Revenue is spread deliberately across three regions and between mature and emerging markets. In FY2025 the split was Asia / Rest of World 42%, Americas 29% and Europe 29%; emerging markets were roughly 45% of sales and mature markets 55% [5].

Source: FY2025 Sales and Results, Net Sales Analysis by Period and Region [6].

The economics are genuinely premium. Gross margin runs near 59% and the reported operating margin was 26.9% of net sales in FY2025; the company held its recurring operating margin roughly flat despite falling volumes, expanding it 64 basis points organically through cost discipline [7]. Marketing investment is deliberately heavy — around 16% of sales — because the brands, not the liquid, are the asset [8]. Cognac and prestige spirits also tie up capital for years: the group carries long-dated maturing inventories that must be laid down long before they can be sold, which is both a moat and a source of inflexibility when demand turns.

Source: FY2025 Universal Registration Document, Key takeaways [9].

The boom, and the reset

The last six years hold the whole story. The pandemic first knocked sales to €8.45bn in FY2020, then a reopening surge in on-trade and travel demand, restocking, and aggressive pricing drove net sales to a record €12.14bn in FY2023. That peak has since unwound: FY2024 fell to €11.60bn and FY2025 to €10.96bn, a reported decline of 5.5% and an organic decline of 3.0% [10].

Sources: FY2025 Sales and Results [11]; prior-year Sales and Results press releases, as reported.

Two engines cooled at the same time, which is what makes this reset unusual. In the United States — the group's single largest profit pool — distributors that had over-ordered during the boom began working inventory back down, so shipments fell faster than consumption. In China, a weak post-COVID consumer recovery hit Martell cognac, and the market was further disrupted by Chinese anti-dumping measures on European brandy that suspended normal cognac sales into travel retail. The H1 FY2026 result, reported in February 2026, showed the pressure had not passed: organic sales fell 5.9%, with the USA down 15% and China down 28%, even as India grew 4% [12].

Management's own framing is that FY2026 is "a transition year," with a Q1 decline from US destocking, soft China demand, India excise changes in Maharashtra, and cognac sales into China duty free resuming only from Q2 [13]. For the medium term (FY2027–FY2029) it guides to organic net sales growth of "+3% to +6%" per year, supported by a €1bn efficiency programme [14]. That range is itself a signal: it sits below the +4% to +7% ambition the group carried into the boom [15], so even management's recovery case embeds a lower cruising speed than the one investors paid for.

What the market has paid

The reset has been punishing for shareholders. The stock closed near €63.9 in early July 2026, down about 29% over one year and roughly 66% over five, against an all-time high above €200 reached in 2021. The market capitalisation is around €16bn. On trailing earnings the shares trade near 11 times, and the dividend — held flat at €4.70 — yields about 7.4%, a level the market usually reserves for businesses it expects to shrink [16].

Source: market data as of 3 July 2026 (Euronext Paris close); dividend per FY2025 Universal Registration Document [17].

A 7%-plus yield on a company that still earns a 27% operating margin and converts to over €1bn of free cash is not a normal pairing. It says the market has stopped treating Pernod Ricard as a reliable compounder and started pricing in the possibility that the last two years are the new baseline rather than a dip. The counter-fact a bull would raise: the same shares changed hands above €200 as recently as 2021 on a portfolio that is largely unchanged, and the sell-side one-year target still sits near €87 — so the disagreement is about durability, not about the assets.

The question this report answers

The central question this report exists to answer: whether the sales decline that began after Pernod Ricard's FY2023 peak is a cyclical trough — an inventory-and-demand reset its premium portfolio, pricing power and emerging-market growth will carry it through — or a structural downshift in spirits demand that has permanently lowered the group's growth and returns; and which of the two the depressed share price is discounting.

Everything that follows tests one side of that question or the other: the durability of the brands and pricing power, the quality of the cash and the balance sheet behind a 3.3x leverage ratio, what the US and China resets actually reveal about end demand, whether India and travel retail can carry the next leg of growth, and what has to be true for an 11x multiple and a 7% yield to be a mispricing rather than a warning.